下肢外周动脉疾病伴运动性肢体症状患者最佳药物治疗的性别差异比较
这项单中心回顾性观察研究纳入877例下肢外周动脉疾病伴运动性肢体症状患者,其中女性182例(20.8%),比较男女在最佳药物治疗(OMT)上的差异。结果显示,调整后男女在OMTbi和OMTtri上均无统计学显著差异,合并冠心病的PAD患者治疗最佳,但整体OMTbi和OMTtri的使用率仍需提高。
要点
- 男女PAD患者在OMTbi和OMTtri上无统计学显著差异
- 合并冠心病的PAD患者OMT使用率最高
- 整体OMTbi和OMTtri使用率仍不充分,需改进
核心结论
- 男女PAD患者在OMTbi或OMTtri上无统计学显著差异。
- 合并冠心病的PAD患者治疗最佳。
- 接受OMTbi和OMTtri的患者数量需要提高。
研究设计与样本
- 单中心观察性回顾性研究,纳入877例下肢PAD伴运动性肢体症状患者,其中女性182例(20.8%)。
- OMTbi定义为抗血栓治疗联合降脂治疗;OMTtri定义为OMTbi联合ACEI或ARB。
- 在全部PAD患者、有下肢血运重建史的患者及合并冠心病的患者三个层面比较男女用药。
主要发现
- 全部PAD患者、有下肢血运重建史患者、合并冠心病患者的OMTbi分别为73.2%、77.8%、88.1%。
- 全部PAD患者、有下肢血运重建史患者、合并冠心病患者的OMTtri分别为52.0%、53.1%、69.7%。
- 调整后全部PAD患者男女OMTbi为75.0% vs. 66.5%(P=0.2838),OMTtri为53.7% vs. 45.6%(P=0.8446)。
- 有下肢血运重建史及合并冠心病的PAD患者中结果类似。
关键数值与推荐
- OMTbi:抗血栓治疗联合降脂治疗。
- OMTtri:OMTbi联合ACEI或ARB。
临床怎么用
- 应关注并提高PAD患者OMTbi和OMTtri的处方率。
- 合并冠心病的PAD患者治疗率较高,可借鉴其管理经验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with lower-extremity peripheral artery disease (PAD) are undertreated with women being less likely than men to receive the optimal medical treatment (OMT). The main objective was to compare the prescription of OMT between men and women in PAD patients with exertional limb symptoms. Secondary objectives were to perform these comparisons in PAD patients with history of lower-extremity revascularization (LER) and in PAD patients with coronary artery disease (CAD). METHODS: This single-center observational retrospective study included PAD patients with exertional limb symptoms. OMTbi was defined as antithrombotic therapy and lipid-lowering therapy. OMTtri was defined as OMTbi associated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers. Comparisons between men and women were performed at 3 levels: in all PAD patients, in PAD patients with LER, and in PAD patients with CAD. RESULTS: Among the 877 included patients, 182 (20.8%) were women. In all PAD patients, PAD patients with LER, and PAD patients with CAD, OMTbi were 73.2%, 77.8%, 88.1%, respectively; whereas, OMTtri were 52.0%, 53.1%, 69.7%, respectively. After adjustments, in all PAD patients, no statistical differences were found between men and women for OMTbi (75.0% vs. 66.5%, P = 0.2838) and OMTtri (53.7% vs. 45.6%, P = 0.8446). Similar results were found in PAD patients with LER and in PAD patients with CAD. CONCLUSION: The findings of this study indicated that there was no statistically significant difference between men and women in terms of OMTbi or OMTtri. PAD Patients with CAD were the best treated. The number of patients who received OMTbi and OMTtri needs to be improved.
引用
- Semaoui Y, Guézais A, Talbot M, et al. Comparisons of Optimal Medical Treatment Between Men and Women in Patients with Lower-Extremity Peripheral Artery Disease and Exertional Limb Symptoms. Ann Vasc Surg. 2025. PMID: 40749826. doi:10.1016/j.avsg.2025.07.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。